In evaluating the impact of BA and GG on NASH and atherosclerosis, LDLR-/- hamsters fed an HFHC diet were treated with BA in drinking water, GG through oral administration, and control water (CON) over an 8-week period. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.